Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JINS Holdings's earnings per share without non-recurring items for the
three
months ended in Feb. 2026 was $0.57.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Feb. 2026 was $2.52.
During the past 12 months, JINS Holdings's average earnings per share (NRI) Growth Rate was 27.50% per year.
During the past 3 years, the average earnings per share (NRI) Growth Rate was 70.70% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was 20.60% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 7.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for JINS Holdings's EPS without NRI or its related term are showing as below:
JNDOF'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -25.7 Med: 20.6 Max: 115.6
Current: 70.7
During the past 13 years, JINS Holdings's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 115.60% per year. The lowest was -25.70% per year. And the median was 20.60% per year.
JNDOF's 3-Year EPS without NRI Growth Rate is ranked better than 93.96% of 662
companies
in the Medical Devices & Instruments industry
Industry Median: 8.15
vs JNDOF: 70.70
JINS Holdings's EPS (Diluted) for the
three
months ended in Feb. 2026 was $0.53.
Its EPS (Diluted) for the trailing twelve months (TTM) ended in Feb. 2026 was $2.30.
JINS Holdings's EPS (Basic) for the
three
months ended in Feb. 2026 was $0.53.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Feb. 2026 was $2.30.
JINS Holdings (OTCPK:JNDOF) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
JINS Holdings EPS without NRI Related Terms
JINS Holdings EPS without NRI Historical Data
* Premium members only.
The historical data trend for JINS Holdings's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JNDOF vs ISRG, BDX, MDLN: EPS without NRI Comparison
For the Medical Instruments & Supplies subindustry, JINS Holdings's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JINS Holdings PE Ratio without NRI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JINS Holdings's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where JINS Holdings's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.52
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JINS Holdings (JNDOF) has a EPS without NRI of $2.52 as of Feb. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on JINS Holdings and its competitors. According to the industry distribution chart, JINS Holdings ranks #40 out of 662 companies in the Medical Devices & Instruments industry, placing it in the top 6%.
Is JINS Holdings' EPS without NRI too high?
JINS Holdings' current EPS without NRI is $2.52. The Medical Devices & Instruments industry median EPS without NRI is 8.15. JINS Holdings' value of $2.52 is 69.1% below this industry median. Based on the distribution chart, JINS Holdings ranks #40 out of 662 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, JINS Holdings has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does JINS Holdings' EPS without NRI compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, JINS Holdings ranks #40 out of 662 companies for EPS without NRI. This places JINS Holdings in the top 6% of its industry — outperforming the majority of peers. The industry median EPS without NRI is 8.15. JINS Holdings' value of $2.52 is 69.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Devices & Instruments company?
The median EPS without NRI among Medical Devices & Instruments companies is 8.15, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JINS Holdings's current EPS without NRI of $2.52 is 69.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on JINS Holdings and its competitors. For the Medical Devices & Instruments industry, the median EPS without NRI is 8.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JINS Holdings's current EPS without NRI is $2.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JINS Holdings stock overvalued right now?
JINS Holdings (JNDOF) has a current EPS without NRI of $2.52. The stock's GF Value™ is $42.68, compared to a current price of $38.43 — trading 10% below its estimated fair value. The current EPS without NRI is $2.52 and 69.1% below the Medical Devices & Instruments industry median of 8.15. JINS Holdings' overall GF Score™ is 96/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For JINS Holdings (JNDOF), the current EPS without NRI is $2.52 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JINS Holdings (JNDOF) Overvalued in 2026?
Based on GuruFocus' analysis, JINS Holdings stock appears to be undervalued.
The current stock price of $38.43 is trading 10% below its estimated GF Value™ of $42.68.
Key valuation signals for JNDOF:
EPS without NRI: $2.52
GF Value™: $42.68 vs. price of $38.43 (10% below fair value)
Industry Position: 69.1% below the Medical Devices & Instruments median (#40 of 662)
No single metric tells the full story. See the JNDOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JINS Holdings Inc is an eyewear retailer that manufactures and sells private-label fashion eyeglasses and sunglasses. It offers prescription eyeglasses and nonprescription fashion or functional eyeglasses. Its inventory is on the shelves, and it charges flat rates with generally no additional charges or options for lens features. Jin has more than 300 stores in Japan as well as locations in China, Taiwan, and the United States. Stores are typically located in high-traffic areas such as shopping centers, malls, and train stations.
96GF Score
Get the complete analysis for JNDOF
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JNDOF has been successfully added to your 
